Brain Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Brain Cancer, including details on symptoms, benign and malignant tumors, gliomas, treatment.

Volume 6 (2009), Issue 9 (September)

1. Efficacy and tolerability of zonisamide as add-on in brain tumor-related epilepsy: preliminary report.
   Acta Neurol Scand, 120(3): 210-2. [Abstract] [Full-text]
2. Pre- and postoperative MR brain imaging with automatic planning and scanning software in tumor patients: an intraindividual comparative study at 3 Tesla.
   J Magn Reson Imaging, 30(3): 672-7. [Abstract] [Full-text]
3. Computer-aided detection of brain tumor invasion using multiparametric MRI.
   J Magn Reson Imaging, 30(3): 481-9. [Abstract] [Full-text]
4. (1)H spectroscopic imaging of human brain at 3 Tesla: comparison of fast three-dimensional magnetic resonance spectroscopic imaging techniques.
   J Magn Reson Imaging, 30(3): 473-80. [Abstract] [Full-text]
5. Could local delivery of bisphosphonates be a new therapeutic choice for hemangiomas?
   Med Hypotheses, 73(4): 495-7. [Abstract] [Full-text]
6. Comparison of automated silver enhanced in situ hybridization and fluorescence in situ hybridization for evaluation of epidermal growth factor receptor status in human glioblastomas.
   Mod Pathol, 22(9): 1263-71. [Abstract] [Full-text]
7. Dysembryoplastic neuroepithelial tumors in pediatric patients.
   Brain Dev, 31(9): 671-81. [Abstract] [Full-text]
8. Gamma Knife surgery for brain metastases from gastrointestinal cancer.
   J Neurosurg, 111(3): 423-30. [Abstract] [Full-text]
9. The quantification of dynamic FET PET imaging and correlation with the clinical outcome in patients with glioblastoma.
   Phys Med Biol, 54(18): 5525-39. [Abstract] [Full-text]
10. Magnetic resonance imaging for radiotherapy planning of brain cancer patients using immobilization and surface coils.
    Phys Med Biol, 54(18): 5381-94. [Abstract] [Full-text]
11. Magnetic resonance imaging-guided adoptive cellular immunotherapy of central nervous system tumors with a T1 contrast agent.
    Magn Reson Med, 62(3): 599-606. [Abstract] [Full-text]
12. Gamma Knife radiosurgery to the surgical cavity following resection of brain metastases.
    J Neurosurg, 111(3): 431-8. [Abstract] [Full-text]
13. Adult craniopharyngiomas: surgical results with a special focus on endocrinological outcomes and recurrence according to pituitary stalk preservation.
    J Neurosurg, 111(3): 572-7. [Abstract] [Full-text]
14. Multifocal meningeal melanocytoma: a new pathological entity or the result of leptomeningeal seeding?
    J Neurosurg, 111(3): 488-91. [Abstract] [Full-text]
15. Reliability of intraoperative high-resolution 2D ultrasound as an alternative to high-field strength MR imaging for tumor resection control: a prospective comparative study.
    J Neurosurg, 111(3): 512-9. [Abstract] [Full-text]
16. Use of morning serum cortisol level after transsphenoidal resection of pituitary adenoma to predict the need for long-term glucocorticoid supplementation.
    J Neurosurg, 111(3): 540-4. [Abstract] [Full-text]
17. Extended endoscopic endonasal transsphenoidal approach for residual or recurrent craniopharyngiomas.
    J Neurosurg, 111(3): 578-89. [Abstract] [Full-text]
18. Stereotactic radiosurgery for metastatic brain tumors: a comprehensive review of complications.
    J Neurosurg, 111(3): 439-48. [Abstract] [Full-text]
19. Outcome of using the histological pseudocapsule as a surgical capsule in Cushing disease.
    J Neurosurg, 111(3): 531-9. [Abstract] [Full-text]
20. Survival and prognostic factors in a series of adults with medulloblastomas.
    J Neurosurg, 111(3): 478-87. [Abstract] [Full-text]
21. Cerebral tumor with extensive rhabdoid features and a favorable prognosis.
    J Neurosurg, 111(3): 492-6. [Abstract] [Full-text]
22. Gliosarcoma: clinical experiences and additional information with MR spectroscopy.
    Neurol Res, 31(8): 873-7. [Abstract] [Full-text]
23. Incidence, clinical manifestations, and course of water and electrolyte metabolism disturbances following transsphenoidal pituitary adenoma surgery: a prospective observational study.
    J Neurosurg, 111(3): 555-62. [Abstract] [Full-text]
24. Brain magnetic resonance imaging changes after sorafenib and sunitinib chemotherapy in patients with advanced renal cell and breast carcinoma.
    J Neurosurg, 111(3): 497-503. [Abstract] [Full-text]
25. Thirty years' experience with Gamma Knife surgery for metastases to the brain.
    J Neurosurg, 111(3): 449-57. [Abstract] [Full-text]
26. Endoscopic pituitary surgery: a systematic review and meta-analysis.
    J Neurosurg, 111(3): 545-54. [Abstract] [Full-text]
27. The predictive value of low-field strength magnetic resonance imaging for intraoperative residual tumor detection. Clinical article.
    J Neurosurg, 111(2): 252-7. [Abstract] [Full-text]
28. Residual nonfunctioning pituitary adenomas: prognostic value of MIB-1 labeling index for tumor progression.
    J Neurosurg, 111(3): 563-71. [Abstract] [Full-text]
29. Tumor ZAC1 expression is associated with the response to somatostatin analog therapy in patients with acromegaly.
    Int J Cancer, 125(9): 2122-6. [Abstract] [Full-text]
30. Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.
    Acta Neuropathol, 118(4): 469-74. [Abstract] [Full-text]
31. Positron emission tomography in the diagnosis and management of intracranial germ cell tumours.
    Horm Res, 72(3): 190-6. [Abstract] [Full-text]
32. Childhood atypical teratoid rhabdoid tumor of the central nervous system: a meta-analysis of observational studies.
    J Pediatr Hematol Oncol, 31(9): 651-63. [Abstract] [Full-text]
33. Cognitive and problem solving training in children with cancer: a pilot project.
    J Pediatr Hematol Oncol, 31(9): 670-7. [Abstract] [Full-text]
34. Association between MGMT promoter hypermethylation and p53 mutation in glioblastoma.
    Cancer Invest, 27(8): 825-9. [Abstract] [Full-text]
35. Dual and opposing roles of primary cilia in medulloblastoma development.
    Nat Med, 15(9): 1062-5. [Abstract] [Full-text]
36. Hybrid mathematical model of glioma progression.
    Cell Prolif, 42(5): 637-46. [Abstract] [Full-text]
37. NDRG4 is required for cell cycle progression and survival in glioblastoma cells.
    J Biol Chem, 284(37): 25160-9. [Abstract] [Full-text]
38. Long-term results of stereotactic radiosurgery in secretory pituitary adenomas.
    J Clin Endocrinol Metab, 94(9): 3400-7. [Abstract] [Full-text]
39. A novel murine model for localized radiation necrosis and its characterization using advanced magnetic resonance imaging.
    Int J Radiat Oncol Biol Phys, 75(2): 527-33. [Abstract] [Full-text]
40. Fully endoscopic transsphenoidal surgery for functioning pituitary adenomas: a retrospective comparison with traditional transsphenoidal microsurgery in the same institution.
    Surg Neurol, 72(4): 336-40. [Abstract] [Full-text]
41. Bromocriptine induces parapoptosis as the main type of cell death responsible for experimental pituitary tumor shrinkage.
    Toxicol Appl Pharmacol, 240(1): 55-65. [Abstract] [Full-text]
42. Pseudoprogression after radiotherapy with concurrent temozolomide for high-grade glioma: clinical observations and working recommendations.
    Surg Neurol, 72(4): 423-8. [Abstract] [Full-text]
43. Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas.
    Br J Cancer, 101(6): 973-82. [Abstract] [Full-text]
44. Relationship between methylation status of ERCC1 promoter and radiosensitivity in glioma cell lines.
    Cell Biol Int, 33(10): 1111-7. [Abstract] [Full-text]
45. Linear-accelerator-based modified radiosurgical treatment of pituitary tumors in cats: 11 cases (1997-2008).
    J Vet Intern Med, 23(5): 1038-44. [Abstract] [Full-text]
46. A 58 year old woman with a corpus callosum nodule at autopsy.
    Brain Pathol, 19(4): 743-4. [Abstract] [Full-text]
47. A 76-year-old man with cognitive and neurological symptoms.
    Brain Pathol, 19(4): 731-4. [Abstract] [Full-text]
48. 6-year-old girl with hydrocephalus.
    Brain Pathol, 19(4): 725-6. [Abstract] [Full-text]
49. EGFRvIII-targeted vaccination therapy of malignant glioma.
    Brain Pathol, 19(4): 713-23. [Abstract] [Full-text]
50. Dendritic cell therapy of high-grade gliomas.
    Brain Pathol, 19(4): 694-712. [Abstract] [Full-text]
51. Immunotherapy of diffuse gliomas: biological background, current status and future developments.
    Brain Pathol, 19(4): 674-93. [Abstract] [Full-text]
52. Interphase cytogenetics for 1p19q and t(1;19)(q10;p10) may distinguish prognostically relevant subgroups in extraventricular neurocytoma.
    Brain Pathol, 19(4): 623-9. [Abstract] [Full-text]
53. Microscopic thrombi in glioblastoma multiforme do not predict the development of deep venous thrombosis.
    Ann Diagn Pathol, 13(5): 291-6. [Abstract] [Full-text]
54. Aspiration biopsy cytomorphology of primary pulmonary germ cell tumor metastatic to the brain.
    Diagn Cytopathol, 37(10): 715-9. [Abstract] [Full-text]
55. Recent progress towards development of effective systemic chemotherapy for the treatment of malignant brain tumors.
    J Transl Med, 7: 77. [Abstract] [Full-text]
56. Extracts of marine sponge Polymastia janeirensis induce oxidative cell death through a caspase-9 apoptotic pathway in human U138MG glioma cell line.
    Invest New Drugs, 27(5): 440-6. [Abstract] [Full-text]
57. Family, demographic and illness-related determinants of HRQL in children with brain tumours in the first year after diagnosis.
    Pediatr Blood Cancer, 53(6): 1092-9. [Abstract] [Full-text]
58. Role of Wnt inhibitory factor-1 and Wnt/wingless signaling in choroid plexus tumors.
    Pediatr Blood Cancer, 53(6): 1152-5. [Abstract] [Full-text]
59. Health-related quality of life in long-term survivors of childhood brain tumors.
    Pediatr Blood Cancer, 53(6): 1086-91. [Abstract] [Full-text]
60. Case report. Glioblastoma multiforme presenting as a haemorrhagic minimally enhancing mass of the trigone.
    Br J Radiol, 82(982): e204-7. [Abstract] [Full-text]
61. Epilepsy and insular Grade II gliomas: an interdisciplinary point of view from a retrospective monocentric series of 46 cases.
    Neurosurg Focus, 27(2): E8. [Abstract] [Full-text]
62. Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449.
    N Engl J Med, 361(12): 1173-8. [Abstract] [Full-text]
63. Distinction between pyogenic brain abscess and necrotic brain tumour using 3-tesla MR spectroscopy, diffusion and perfusion imaging.
    Br J Radiol, 82(982): 813-20. [Abstract] [Full-text]
64. Craniopharyngiomas in the posterior fossa: a rare subgroup, diagnosis, management and outcomes.
    J Neurol Neurosurg Psychiatry, 80(10): 1150-4. [Abstract] [Full-text]
65. Serial stereotactic biopsy of brainstem lesions in adults improves diagnostic accuracy compared with MRI only.
    J Neurol Neurosurg Psychiatry, 80(10): 1134-9. [Abstract] [Full-text]
66. Analysis of IDH1 and IDH2 mutations in Japanese glioma patients.
    Cancer Sci, 100(10): 1996-8. [Abstract] [Full-text]
67. Cellular characterization of the peritumoral edema zone in malignant brain tumors.
    Cancer Sci, 100(10): 1856-62. [Abstract] [Full-text]
68. Heat shock protein 70-binding protein 1 is highly expressed in high-grade gliomas, interacts with multiple heat shock protein 70 family members, and specifically binds brain tumor cell surfaces.
    Cancer Sci, 100(10): 1870-9. [Abstract] [Full-text]
69. Temozolomide treatment of a pituitary carcinoma and two pituitary macroadenomas resistant to conventional therapy.
    Eur J Endocrinol, 161(4): 631-7. [Abstract] [Full-text]
70. High incidence of low O(6)-methylguanine DNA methyltransferase expression in invasive macroadenomas of Cushing's disease.
    Eur J Endocrinol, 161(4): 553-9. [Abstract] [Full-text]
71. Brain tumor immunotherapy with type-1 polarizing strategies.
    Ann N Y Acad Sci, 1174: 18-23. [Abstract] [Full-text]
72. Recovery from neurological sequelae secondary to oncological brain surgery in an adult growth hormone-deficient patient after growth hormone treatment.
    J Rehabil Med, 41(9): 775-7. [Abstract] [Full-text]
73. Forniceal glioma in children. Clinical article.
    J Neurosurg Pediatr, 4(3): 249-53. [Abstract] [Full-text]
74. Endoscopic transventricular positioning of intracystic catheter for treatment of craniopharyngioma. Technical note.
    J Neurosurg Pediatr, 4(3): 245-8. [Abstract] [Full-text]
75. Prevalence of pineal cysts in children and young adults. Clinical article.
    J Neurosurg Pediatr, 4(3): 230-6. [Abstract] [Full-text]
76. Tissue expression of manganese superoxide dismutase is a candidate prognostic marker for glioblastoma.
    Oncology, 77(3): 178-81. [Abstract] [Full-text]
77. Angiogenesis inhibitor DC101 delays growth of intracerebral glioblastoma but induces morbidity when combined with irradiation.
    Cancer Lett, 285(1): 39-45. [Abstract] [Full-text]
78. Modulation of invasive properties of CD133+ glioblastoma stem cells: a role for MT1-MMP in bioactive lysophospholipid signaling.
    Mol Carcinog, 48(10): 910-9. [Abstract] [Full-text]
79. Disparities in access to pediatric neurooncological surgery in the United States.
    Pediatrics, 124(4): e688-96. [Abstract] [Full-text]
80. Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma.
    J Clin Oncol, 27(28): 4733-40. [Abstract] [Full-text]

© 2004-2010 Brain Cancer Research Today. All Rights Reserved.